Portrait of French-speaking minorities with respect to COVID-19 vaccinations

CCDR

Volume 49-7/8, July/August 2023: Enteric Diseases: A Major Health Problem in Canada

Survey Report

Portrait of French-speaking minorities with respect to vaccination against COVID-19

Chloé Desjardins1, Jennifer Lacroix Haraysm1, Joseph Abdoulnour2, Manon Denis-LeBlanc2,3, Daniel Hubert1, Salomon Fotsing1,2,3, Diane Bouchard Lamothe1, Sylvain Boet2,4,5,6,7,8

Affiliations

1 Francophone Affairs, Faculty of Medicine, University of Ottawa, Ottawa, ON

2 Institut du Savoir Montfort, Ottawa, Ottawa, ON

3 Department of Family Medicine, University of Ottawa, Ottawa, ON

4 Faculty of Education, University of Ottawa, Ottawa, ON

5 Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON

6 Department of Innovation in Medical Education, University of Ottawa, Ottawa, ON

7 Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON

8 Keenan Research Centre at the Li Ka Shing Knowledge Institute, Toronto, ON

Correspondence

jlacroi9@uottawa.ca

Suggested citation

Desjardins C, Lacroix Haraysm J, Abdoulnour J, Denis-LeBlanc M, Hubert D, Fotsing S, Bouchard Lamothe D, Boet S. Portrait of French-speaking minorities with respect to vaccination against COVID-19. Can Commun Dis Rep 2023;49(7/8):320–30. https://doi.org/10.14745/ccdr.v49i78a04

Keywords: vaccines, vaccine hesitancy, Francophone minorities, community survey

Abstract

Background: The coronavirus disease 2019 (COVID-19) vaccination campaign highlighted the requirement to better understand the needs of different populations. French-speaking minorities (FSMs) have greater difficulty accessing quality care in French, and this problem was exacerbated during the COVID-19 pandemic.

Objective: The aim of this survey was to develop a descriptive portrait of the health needs of FSMs in relation to the COVID-19 vaccination campaign by describing their vaccination status, attitudes and beliefs compared with English-speaking majorities.

Methods: A survey was conducted among eligible participants using convenience sampling. Data measurement includes a descriptive statistical comparison using analysis of the variance, univariate logistic regressions and a two-proportions z-test.

Results: Of the 1,505 respondents (554 FSMs vs. 951 English speakers), the FSMs have an average age of 51.4 years and 89.2% are Canadian citizens. Vaccination of children was preponderant among English speakers (74.2% vs. 86.3%), including against COVID-19 (58.6% vs. 73.9%). A higher proportion of FSMs had gotten vaccinated in order to obtain a vaccine passport (39% vs. 29.3%). Among the unvaccinated, FSMs were more likely to question the efficacy of vaccines (60% vs. 36.4%). Canadian citizen FSMs with higher education could be divided in relation to the vaccine regimen.

Conclusion: This survey revealed differences between FSMs and the English-speaking majority in their perceptions of vaccine efficacy, particularly vaccination of children, and a polarization of attitudes/beliefs among FSMs according to certain sociodemographic factors.

Introduction

The coronavirus disease 2019 (COVID-19) vaccination campaign highlighted the requirement to better understand the needs of different Canadian populations during a pandemic. The lack of data on the needs of linguistic minoritiesFootnote 1Footnote 2Footnote 3 had a significant impact on vaccine uptake and trust in healthcare institutionsFootnote 4Footnote 5.

French-speaking minorities (FSMs) have greater difficulty accessing quality care in FrenchFootnote 6Footnote 7Footnote 8Footnote 9Footnote 10Footnote 11Footnote 12, which is one of the problems exacerbated during a pandemic Footnote 8Footnote 12Footnote 13. However, vaccine uptake is influenced by multiple factors linked to the sociocultural context, including values, morality, accessibility and therapeutic experience, requiring adapted medical practicesFootnote 14Footnote 15Footnote 16Footnote 17. This study is necessary to fill the knowledge gap on the subject and improve the active offer.

Given the fragmented nature of Canadian FrancophonieFootnote 18, it is difficult to establish an overall picture of the needs of FSMs based on up-to-date evidence. An existing surveyFootnote 19 explores some relevant areas, but does not provide a breakdown by language, at least not in publicly available data. This survey, carried out between May 1 and June 30, 2022, aims to describe the health needs of FSMs in relation to the COVID-19 vaccination campaign through the lens of vaccination status, attitudes and beliefs, and provides for a comparison with English-speaking majorities.

Methods

This article was written according to the guidelines of Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES)Footnote 20.

Population, time and place

The survey was conducted over an eight-week period ending on June 30, 2022, among FSMs and English speakers outside Québec, Canada. The study defines FSMs as residents outside Québec whose preferred language is French, and Anglophones as residents outside Québec whose preferred language is English. Given the rapid evolution of the pandemic, convenience sampling was used.

Link to the research objective

The descriptive portrait of FSMs vis-à-vis the COVID-19 vaccination campaign includes the collection of sociodemographic data, vaccination status, attitudes and beliefs.

Development of the survey questionnaire

The questionnaire (Supplemental material, Survey) was designed by the research team based on a validated surveyFootnote 19 by Statistics Canada. To meet the requirements of the study, questions dealing with language, attitudes and beliefs were added before conducting a pilot study with 30 participants drawn from the mailing list of Léger Marketing Inc.

Sampling technique

Participants were recruited primarily via the sampling strategy, the mailing list of Léger Marketing Inc. and Canadian Francophone organizations (Supplemental material, Survey invitation letter). The sample was created taking into account the response rates for each age category and the quotas required to obtain a representative sample. Representative quotas were established for age, gender and province. The sample was sent out strategically to ensure representativeness. For example, attention was focused on the 18 to 24 age group, as these respondents are generally harder to reach, while less attention was paid to the 65+ age group, as they are conversely much easier to reach. This required constant attention to the quotas defined in the survey platform, while ensuring random selection. An invitation letter, a consent form and the questionnaire were distributed to those who met the inclusion criteria.

Informed consent

The study was approved by the University of Ottawa Research Ethics Board (H-02-22-7648). A consent form had to be completed by participants prior to conducting the survey.

Optimizing response rates

The survey was made available on FocusVision Decipher (Forsta, 2022) and on the LEO mobile app (Léger Marketing Inc., 2020), in addition to being widely distributed via the social networks of the University of Ottawa Faculty of Medicine’s Francophone Affairs. Participants were invited to share the survey, allowing snowball sampling to be used to optimize the response rate.

Measurement

Data measurement was carried out in accordance with two research questions designed to identify 1) the vaccination status, attitudes and beliefs of FSMs compared with English speakers, and 2) the sociodemographic characteristics of FSMs in relation to vaccination status, attitudes and beliefs.

Sociodemographic data includes: province/territory of residence, age, gender, income, education, marital status, ethnicity, citizenship and health status. Vaccination status includes COVID-19 vaccine doses, willingness to follow the recommended vaccine regimen, and vaccination of children (ages 5 to 11 years). Attitudes include reasons for uptake and hesitancy, as well as trusted sources of information. Beliefs include vaccine safety, perceived risks and efficacy, health practices and social responsibility.

Analysis

Descriptive statistics were calculated and analyzed using SPSS (version 22.0). Continuous variables were presented as means and standard deviations, and categorical variables as totals and/or percentages. Analyses of variance (ANOVA) were performed to examine significant differences in continuous variables. Univariate logistic regressions were performed to determine the associations between FSMs and English speakers, and also sociodemographic variables with vaccination status and belief. The findings are presented as odds ratios (OR) with 95% confidence intervals (CI), as well as the likelihood chi-squared statistic. A two-proportions z-test was performed for multiple-response questions to compare proportions between groups; the Bonferroni correction was used for multiple comparisons. A p-value of less than 0.05 indicates a statistically significant difference.

Findings

The sample comprised 1,505 participants: 554 FSMs and 951 English speakers. The findings include a 100% response rate for each participant, giving n=554 (FSMs) and n=951 (English speakers). The sociodemographic data are presented below (Table 1).

Table 1: Sociodemographic characteristics of French-speaking minority participants and English-speaking participants
Characteristics

% FSM
(n=554)

% English speakers
(n=951)

Age (years)

Mean; standard deviation

51.4; 16.9

48.1; 17.4

Median

53.0

47.0

18–24

4.7

11.1

25–34

17.0

15.3

35–44

14.6

17.0

45–54

17.5

20.1

55–64

20.9

17.5

65–74

17.5

9.3

≥75

7.8

9.6

Gender

Female

61.2

50.2

Male

38.8

49.8

Other

0.0

0.0

Prefer not to answer

0.0

0.0

Province

Ontario

47.1

50.4

New Brunswick

33.4

2.4

British Columbia

6.5

17.8

Alberta

6.5

14.2

Manitoba

2.7

4.9

Saskatchewan

1.4

4.1

Nova Scotia

1.4

3.7

Nunavut

0.4

0.0

Newfoundland and Labrador

0.2

2.1

Prince Edward Island

0.2

0.4

Yukon

0.2

0.0

Income

≤$30,000

12.4

13.2

$30,000 to $60,000

23.4

23.6

$60,000 to $90,000

20.7

22.0

$90,000 to $120,000

17.4

17.9

$120,000 to $150,000

11.3

9.8

>$150,000

14.8

13.5

Education

Less than a high school diploma or equivalent

3.1

1.2

High school diploma or certificate of equivalence

15.6

18.2

Trade certificate or diploma

5.6

6.9

College, CEGEP or other non-university certificate or diploma

20.0

22.4

University certificate or diploma below bachelor level

5.1

6.8

Bachelor’s degree

30.0

30.5

University certificate, diploma or degree above bachelor level

20.5

14.0

Marital status

Single

23.4

24.1

Couple

49.5

34.9

Family

27.2

40.9

Indigenous status

North American First Nation

1.3

2.1

Métis

2.5

2.0

Inuk (Inuit)

0.0

0.3

Ethnicity

Arab

0.9

1.4

Southeast Asian

1.6

0.5

West Asian

0.7

0.2

Caucasian

70.8

91.5

Chinese

8.8

1.3

Korean

0.6

0.0

Japanese

0.5

0.0

Latin American

1.5

0.5

African American

1.8

2.5

Filipino

1.3

0.0

South Asian

6.6

0.5

Other

4.7

1.6

Citizenship status

Canadian citizen by birth

89.2

77.2

Canadian citizen by naturalization

7.6

18.6

Permanent resident

2.5

2.7

None

0.7

1.5

State of health

Obesity

9.4

9.2

Heart and/or vessel disease

4.7

4.7

Diabetes

10.1

6.3

Liver disease

0.7

0.4

Chronic kidney disease

0.0

0.7

Alzheimer’s disease

0.2

0.0

Immunodeficiency

3.3

3.3

Lung disease

7.2

6.7

None of these health problems

64.3

68.7

Table 1 abbreviations

Abbreviation: FSM, French-speaking minority


Vaccination status

Differences between French-speaking minorities and English speakers

According to the univariate regression values, FSMs were less willing to have their children vaccinated against preventable diseases (74.2% vs. 86.3%) (χ2[1, N=440]=7.069, p=0.008; OR=0.455 [95% CI: 0.259–0.799]), against COVID-19 (58.6% vs. 73.9%) (χ2[1, N=436]=7.531, p=0.006; OR=0.500 [95% CI: 0.306–0.815]) or to follow the recommended vaccine regimen (0.0% vs. 22.0%) (χ2[3, N=126]=16.879, p=0.001) (Table 2).

Table 2: Vaccination status among French-speaking minorities and English speakers
Vaccination status

% FSM
(n=554)

% English speakers
(n=951)

Likelihood chi-squared

Approx. sig. (bilateral)Footnote a

OR

95% CI

Adult vaccinated against COVID-19

Yes

93.60

91.80

1.763

0.184

0.756

0.500

1.144

No

6.40

8.20

N/A

N/A

N/A

COVID-19 vaccination doses

1 dose

0.80

1.30

5.758

0.124

0.472

0.144

1.549

2 doses

19.50

23.50

0.640

0.429

0.953

3 doses

66.70

65.20

0.790

0.559

1.116

4 doses

13.00

10.10

N/A

N/A

N/A

Plausibility of following the recommended full vaccine regimen (vaccinated adult)

Very likely

62.20

62.60

2.463

0.482

0.881

0.559

1.390

Somewhat likely

20.10

22.50

0.792

0.483

1.300

Unlikely

11.10

9.10

1.082

0.623

1.879

Very unlikely

6.60

5.90

N/A

N/A

N/A

Plausibility of following the recommended full vaccine regimen (unvaccinated adult)

Very likely

2.90

6.40

4.523

0.210

0.354

0.039

3.194

Somewhat likely

5.70

17.90

0.253

0.053

1.200

Unlikely

17.10

16.70

0.817

0.277

2.405

Very unlikely

74.30

59.00

N/A

N/A

N/A

Previous vaccination for children (against other diseases)

Yes

74.20

86.30

7.069

0.008

0.455

0.259

0.799

No

25.80

13.70

N/A

N/A

N/A

Children vaccinated against COVID-19

Yes

58.60

73.90

7.531

0.006

0.500

0.306

0.815

No

41.40

26.10

N/A

N/A

N/A

COVID-19 vaccination doses

1 dose

29.20

17.20

3.382

0.184

2.064

0.784

5.433

2 doses

54.20

62.60

1.053

0.446

2.486

3 doses

16.70

20.30

N/A

N/A

N/A

Plausibility of following the recommended full vaccine regimen (children)

Very likely

0.0

22.0

16.879

0.001

6.84E-10

6.84E-10

6.84E-10

Somewhat likely

28.6

34.10

0.473

0.180

1.247

Unlikely

28.6

19.8

0.815

0.296

2.246

Very unlikely

42.9

24.2

N/A

N/A

N/A

Table 2 abbreviations

Abbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; FSM, French-speaking minority; N/A, not applicable; OR, odds ratio

Table 2 Footnote a

Approx. sig. (bilateral) is a p-value of less than 0.05 for univariate analyses is considered significant

Table 2 Return to footnote a referrer


Differences according to sociodemographic data

Compared with those born outside the country, Canadian-born FSMs are more inclined to not follow the recommended vaccine regimen (85.2% vs. 37.5%) (χ2[3, N=35]=10.714, p=0.013; OR=7.667 [95% CI: 1.035–56.770]), but have more doses (67.7% and 13.6% vs. 56.9% and 7.8%) (χ2[3, N=513]=9.848, p=0.020; OR=15.750 [95% CI: 1.736–142.882]). Among those, individuals with a college/certificate education are less inclined to agree with the vaccine regimen compared with those with a higher education (52.7% vs. 75.7%) (χ2[9, N=509]=22.968, p=0.006; OR=0.313 [95% CI: 0.109–0.903]). More FSMs are vaccinated in Ontario (96.2% vs. 86.2% [West] and 93.8% [Atlantic]) (χ2[2, N=547]=10.317, p=0.017; OR=4.012 [95% CI: 1.695–9.497]) receive more doses compared with other regions (20% vs. 8.6% [West] and 5.6% [Atlantic]) (χ2[6, N=511]=43.713, p<0.001). Men (18.9% vs. 9.3%, women) (χ2[3, N=514]=14.229, p=0.003; OR=2.044 [95% CI: 1.203–3.471]) and older individuals (52.2 ± 16.1 and 68.8 ± 11.2 years vs. 40.8 ± 18.3 and 40.9 ± 12.2 years; F(3, 510)=46.58, p<0.001) more often had 3–4 doses. Among FSMs with vaccinated children, a high income was preponderant (87% [>$120,000] vs. 56.8% [$60,000 to $120,000] vs. 34.6% [<$60,000]) (χ2[2, N=86]=14.963, p=0.001; OR=12.593 [95% CI: 2.931–54.107]).

Attitudes

Differences between French-speaking minorities and English speakers

There are two significant differences: a greater proportion of FSMs had gotten vaccinated to obtain the vaccine passport (39% vs. 29.3%, p<0.001); among the unvaccinated, more FSMs questioned the efficacy of the COVID-19 vaccine (60.0% vs. 36.4%, p=0.019) (Table 3).

Table 3: Vaccination attitudes between French-speaking minorities and English speakers

Vaccination attitudes

FSMs

English speakers

Statistical z-testFootnote a

p-value

n

%

n

%

Reasons for vaccination (vaccinated adult)Footnote b

Vaccination is mandated by my workplace

112

21.7%

163

18.8%

−1.34

0.1811

Vaccination passport

201

39.0%

254

29.3%

−3.72

0.0002

I want to protect myself against serious illness

395

76.7%

686

79.0%

−1.02

0.3099

Return to normal life

275

53.4%

433

49.9%

−1.26

0.2064

I want to protect others

329

63.9%

574

66.1%

−0.85

0.3964

Leisure

179

34.8%

288

33.2%

−0.60

0.5487

Other

14

2.7%

22

2.5%

−0.21

0.8355

Reasons for vaccine hesitancy (unvaccinated adult)Footnote c

The vaccine is not recommended for me

5

14.3%

7

9.1%

−0.83

0.4088

I do not have the necessary information to make a decision

4

11.4%

8

10.4%

−0.17

0.8688

I know too many people who have had side effects

12

34.3%

32

41.6%

−0.73

0.4642

I’m afraid

5

14.3%

9

11.7%

−0.39

0.6994

I am not at a great risk of contracting COVID-19

9

25.7%

17

22.1%

−0.42

0.6720

If I get COVID-19, I won’t be very sick

6

17.1%

17

22.1%

0.60

1.4517

We do not know the long-term side effects

22

62.9%

44

57.1%

−0.57

0.5681

I don’t know who to believe

3

8.6%

8

10.4%

−0.30

0.7640

I don’t know how, when or where to get vaccinated

0Footnote d

0.0%

1

1.3%

N/AFootnote d

N/AFootnote d

I should be given a choice

18

51.4%

36

46.8%

−0.46

0.6456

There was a problem with the appointment

0Footnote d

0.0%

2

2.6%

N/AFootnote d

N/AFootnote d

I didn’t have time

0Footnote d

0.0%

4

5.2%

N/AFootnote d

N/AFootnote d

I’ve already had COVID-19

3

8.6%

15

19.5%

−1.46

0.1446

I don’t want to get vaccinated at this time

14

40.0%

25

32.5%

−0.78

0.4370

In general, I don’t believe in vaccines

4

11.4%

10

13.0%

−0.23

0.8169

The vaccine I want is not available or has not been offered to me

0Footnote d

0.0%

2

2.6%

N/AFootnote d

N/AFootnote d

I don’t trust the vaccine offered to me

10

28.6%

20

26.0%

−0.29

0.7731

I don’t trust the health system

5

14.3%

10

13.0%

−0.19

0.8513

Cultural, philosophical or religious reasons

5

14.3%

7

9.1%

−0.83

0.4088

I’m pregnant or plan to become pregnant

1

2.9%

3

3.9%

−0.28

0.7833

I’m not sure that vaccines against COVID-19 are effective

21

60.0%

28

36.4%

−2.34

0.0194

Other

1

2.9%

10

13.0%

−1.67

0.0947

Reasons for hesitancy concerning vaccination of childrenFootnote e

The vaccine is not recommended for them

7

20.0%

29

32.2%

−1.35

0.1754

I do not have the necessary information to make a decision

8

22.9%

11

12.2%

−1.49

0.1370

I know too many people who have had side effects

5

14.3%

14

15.6%

−0.18

0.8591

I’m afraid and/or my children are afraid

2

5.7%

6

6.7%

−0.20

0.8451

My children are not at high risk of contracting COVID-19

4

11.4%

11

12.2%

−0.12

0.9024

If they contract COVID-19, my children won’t be very sick

8

22.9%

10

11.1%

−1.68

0.0931

We do not know the long-term side effects of the vaccine that was offered to me for them

11

31.4%

27

30.0%

−0.16

0.8761

I don’t know who to believe

3

8.6%

3

3.3%

−1.23

0.2187

I don’t know how, when or where to get my children vaccinated

0Footnote d

0.0%

1

1.1%

N/AFootnote d

N/AFootnote d

I should be given a choice

8

22.9%

16

17.8%

−0.65

0.5174

There was a problem with the appointment

1

2.9%

2

2.2%

−0.21

0.8350

I didn’t have time

2

5.7%

2

2.2%

−1.00

0.3192

They’ve already had COVID-19

6

17.1%

10

11.1%

−0.91

0.3648

I don’t want my children to get vaccinated at this time

5

14.3%

19

21.1%

−0.87

0.3844

In general, I don’t believe in vaccines

0Footnote d

0.0%

6

6.7%

N/AFootnote d

N/AFootnote d

The vaccine I want for my children is not available or has not been offered to me

1

2.9%

3

3.3%

−0.14

0.8920

I don’t trust the vaccine offered to me

4

11.4%

10

11.1%

−0.05

0.9597

I don’t trust the health system because of a bad experience

3

8.6%

5

5.6%

−0.62

0.5362

Cultural, philosophical or religious reasons

0Footnote d

0.0%

3

3.3%

N/AFootnote d

N/AFootnote d

I’m not sure that vaccines against COVID-19 are effective

5

14.3%

21

23.3%

−1.12

0.2631

In general, the risks associated with vaccines are greater than the benefits

6

17.1%

15

16.7%

−0.06

0.9490

Other

0Footnote d

0.0%

4

4.4%

N/AFootnote d

N/AFootnote d

Trusted sources of information on COVID-19 vaccinationFootnote f

Friends, family members or acquaintances

51

9.3%

132

13.9%

−2.64

0.008

My physician

379

69.0%

657

69.4%

−0.14

0.890

My pharmacist

238

43.4%

380

40.1%

−1.23

0.220

Other healthcare professionals (e.g. nurses)

228

41.5%

439

46.4%

−1.82

0.069

Community leaders

17

3.1%

35

3.7%

−0.61

0.540

Politicians

24

4.4%

18

1.9%

−2.80

0.005

Social media

23

4.2%

26

2.7%

−1.52

0.129

Alternative medicine professionals

32

5.8%

48

5.1%

−0.63

0.527

Public health authorities

335

61.0%

529

55.9%

−1.95

0.051

Health scientists and researchers

352

64.1%

593

62.6%

−0.58

0.561

World Health Organization (WHO)

267

48.6%

437

46.1%

−0.93

0.351

Pharmaceutical companies

24

4.4%

70

7.4%

−2.34

0.020

Other

29

5.3%

59

6.2%

−0.75

0.451

Means of validating COVID-19 vaccination informationFootnote g

Confirm with other sources

338

61.6%

558

59.1%

−0.94

0.3481

Click on the link to read the full article

230

41.9%

461

48.8%

−2.59

0.0095

Check the date of the information

204

37.2%

354

37.5%

−0.13

0.8949

Check the number of likes or shares

6

1.1%

29

3.1%

−2.47

0.0134

Research the author or source

242

44.1%

407

43.1%

−0.36

0.7154

Read the comments or take note of the discussions on the subject

93

16.9%

164

17.4%

−0.21

0.8300

Consult friends and family

59

10.7%

142

15.0%

−2.33

0.0196

Check the credibility of the URL

203

37.0%

339

35.9%

−0.41

0.6785

Other

60

10.9%

86

9.1%

1.15

1.7482

Table 3 abbreviations

Abbreviations: COVID-19, coronavirus disease 2019; FSM, French-speaking minority; N/A, not applicable

Table 3 Footnote a

Statistical z-test results are based on bilateral tests with a significance level of 0.05. The tests are adjusted for all pairwise comparisons within a row of each innermost sub-table, using the Bonferroni correction

Table 3 Return to footnote a referrer

Table 3 Footnote b

Total N for FSMs=35 and for English speaking=77

Table 3 Return to footnote b referrer

Table 3 Footnote c

This category is not used in the comparisons as its proportion of columns is equal to zero

Table 3 Return to footnote c referrer

Table 3 Footnote d

Total N for FSMs=515 and for English speaking=868

Table 3 Return to footnote d referrer

Table 3 Footnote e

Total N for FSMs=35 and for English speaking=90

Table 3 Return to footnote e referrer

Table 3 Footnote f

Total N for FSMs=549 and for English speaking=947

Table 3 Return to footnote f referrer

Table 3 Footnote g

Total N for FSMs=549 and for English speaking=944

Table 3 Return to footnote g referrer


Differences according to sociodemographic data

French-speaking minorities who are Canadian citizens by birth are mainly vaccinated for a return to normal life (55% vs. 39%, p=0.034) and protection against serious illness (79% vs. 59%, p=0.002). To obtain information on COVID-19, they mainly consulted family and friends (10% vs. 20%, p=0.015), pharmacists (45% vs. 30%, p=0.026) and public health authorities (63% vs. 47%, p=0.016). Ontarians are more confident in the safety and efficacy of vaccines/health measures (58.1% vs. 38.9% [West] and 42.7% [Atlantic]) (χ2[6, N=545]=19.141, p=0.004; OR=1.829 [95% CI: 0.786–4.255]). This confidence is also preponderant among men (58.4% vs. 43.4%, women) (χ2[3, N=548]=12.337, p=0.006; OR=1.724 [95% CI: 0.804–3.695]) who are more willing to get vaccinated to protect themselves against serious illness (83% vs. 72.6%, p<0.001). The higher the level of education, the more likely it was that article publication dates would be consulted to validate information (40% vs. 24%, p=0.008) and that scientific professionals would be regarded with confidence (76% vs. 56%, p<0.001).

Beliefs

Differences between French-speaking minorities and English speakers

FSMs frequently disagreed with the efficacy of herd immunity (Table 4).

Table 4: Vaccination beliefs among French-speaking minorities and English speakers

Vaccination beliefs

% FSM
(n=554)

% English speakers
(n=951)

Likelihood chi-squared

Approx. sig. (bilateral)

OR

95% CI

Vaccines are safe despite the risks

Strongly agree

52.00

51.40

5.561

0.135

3.009

1.023

8.854

Agree

40.60

39.70

2.971

1.114

7.923

Disagree

4.90

5.60

1.876

0.692

5.084

Strongly disagree

2.50

3.30

N/A

N/A

N/A

COVID-19 vaccines are safe, despite the risks

Strongly agree

49.30

48.50

6.656

0.084

0.290

0.089

0.943

Agree

36.70

36.90

0.258

0.090

0.743

Disagree

8.00

9.00

0.342

0.134

0.875

Strongly disagree

6.00

5.70

N/A

N/A

N/A

I distrust COVID-19 vaccines because they were developed too quickly

Strongly agree

10.30

9.60

1.981

0.576

0.692

0.366

1.310

Agree

15.90

16.40

0.763

0.468

1.245

Disagree

39.80

38.60

0.816

0.588

1.134

Strongly disagree

34.00

35.40

N/A

N/A

N/A

By getting the COVID-19 vaccine, I am protecting myself against severe forms of this disease

Strongly agree

52.60

50.30

3.161

0.367

1.614

0.622

4.188

Agree

35.60

36.70

1.251

0.501

3.124

Disagree

7.10

7.40

1.556

0.642

3.772

Strongly disagree

4.70

5.60

N/A

N/A

N/A

Physical distancing, frequent hand washing and wearing a mask are effective methods of slowing the spread of COVID-19

Strongly agree

58.00

56.10

3.332

0.343

0.734

0.295

1.828

Agree

34.60

35.60

0.616

0.250

1.514

Disagree

4.50

6.20

0.517

0.197

1.353

Strongly disagree

2.90

2.10

N/A

N/A

N/A

Physical distancing, frequent hand washing and wearing a mask are enough to protect me against COVID-19

Strongly agree

13.60

11.60

1.311

0.727

0.853

0.537

1.356

Agree

28.50

29.50

0.795

0.529

1.196

Disagree

43.20

43.30

0.896

0.625

1.284

Strongly disagree

14.70

15.70

N/A

N/A

N/A

Only those at risk of becoming seriously ill due to COVID-19 need to be vaccinated

Strongly agree

6.90

6.00

3.537

0.316

0.822

0.469

1.443

Agree

12.90

12.20

1.012

0.613

1.670

Disagree

36.70

35.40

0.771

0.550

1.080

Strongly disagree

43.60

46.40

N/A

N/A

N/A

By getting vaccinated against COVID-19, I’m helping to protect the health of others in my community

Strongly agree

57.50

56.10

3.842

0.279

1.862

0.817

4.244

Agree

30.50

29.20

1.564

0.701

3.490

Disagree

6.50

8.60

1.032

0.464

2.297

Strongly disagree

5.50

6.00

N/A

N/A

N/A

I prefer to develop immunity to COVID-19 by catching the disease than through the vaccination

Strongly agree

9.40

7.10

48.820

0.000

5.716

2.997

10.901

Agree

15.60

14.70

3.693

2.207

6.181

Disagree

40.60

29.30

2.918

2.060

4.134

Strongly disagree

34.40

48.90

N/A

N/A

N/A

Those who have already had COVID-19 do not need to get vaccinated

Strongly agree

5.60

6.50

13.088

0.004

0.522

0.253

1.077

Agree

12.00

12.80

0.961

0.560

1.647

Disagree

49.00

39.00

1.489

1.079

2.055

Strongly disagree

33.40

41.70

N/A

N/A

N/A

Table 4 abbreviations

Abbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; FSM, French-speaking minority; N/A, not applicable; OR, odds ratio


Differences according to sociodemographic data

French-speaking minorities with high incomes, >$120,000, were not wary of the rapid development of the vaccines (47.2% [>$120,000] vs. 32.2% [$60,000 to $120,000] and 25.0% [<$60,000]) (χ2[6, N=546]=33.064, p<0.001; OR=6.381 [95% CI: 2.454–16.592]), did not believe in the stand-alone efficacy of physical distancing (21.7% [>$120,000] vs. 12.5% [$60,000 to $120,000] vs. 11.9% [<$60,000]) (χ2[6, N=544]=15.805, p=0.015; OR=3.836 [95% CI: 1.671–8.805]), or herd immunity (46.8% [>$120,000] vs. 30.8% [$60,000 to $120,000] vs. 29.1% [<$60,000]) (χ2[6, N=545]=20.787, p=0.002; OR=5.789 [95% CI: 2.080–16.112]) and that a previous diagnosis would result in less serious illness (42.6% [>$120,000] vs. 30.9% [$60,000 to $120,000] vs. 29.1% [<$60,000]) (χ2[6, N=544]=15.185, p=0.019; OR=5.965 [95% CI: 1,659–21,449]).

Discussion

Summary of key findings

The survey highlights three findings of interest: a polarization of attitudes/beliefs according to citizenship and education, vaccine uptake for a return to normal, and significant hesitancy concerning vaccination of children.

Comparative analysis

Compared with English speakers, FSMs show a polarization of attitudes/beliefs according to certain sociodemographic characteristics. Among FSMs, Canadian-born citizens with a higher education were more likely to completely disagree or agree with the recommended vaccine regimen. This trend is noted by other studies in high-income countriesFootnote 17. The literature indicates that mixed attitudes may stem from inconsistent information from official sources Footnote 21Footnote 22Footnote 23Footnote 24, becoming a risk to communication and patient disregard for medical careFootnote 25.

According to the literature, the prospect of a “return to normal” is strong motivation for vaccine uptakeFootnote 4Footnote 21. Although FSMs generally doubted its efficacy, they mainly got vaccinated to obtain the vaccine passport and to protect themselves against serious illness, especially in the case of men. Given the inconsistency of information, also felt among healthcare professionalsFootnote 25, FSMs were not always able to count on the news and relied on the recommendations of government agencies, promising a return to normality thanks to vaccinationFootnote 24Footnote 26.

Although FSMs are often described as an older populationFootnote 7Footnote 27, this survey was designed to be representative of all FSM generations. Despite the low representation of French-speaking parents with young children, vaccination hesitancy for children is of particular interest. Vaccine hesitancy (COVID-19 and other diseases) for children is more pronounced among FSMs, who are less likely to follow the vaccine regimen, unless they have a high income. In a broader context, the efficacy of COVID-19 vaccines in children has been widely disputed in literatureFootnote 17Footnote 28.

The problem of childhood vaccination, which existed prior to the emergence of COVID-19Footnote 17 and led to parental vaccine hesitancy during this pandemicFootnote 28, could be caused by sub-optimal physician-patient communicationFootnote 4Footnote 29. The finding of this study could indicate greater inaccessibility for linguistic minorities. We hypothesize that the current shortage of family physicians in rural and urban settingsFootnote 30Footnote 31, and by extension a lack of accessibility to bilingual health professionals, could contribute to an exacerbation of the problem of vaccination of children during a health crisis. Vaccination of children and parental hesitancy should be the subject of further research to pursue this line of thought and optimize access to care.

Strengths and weaknesses

Considering the rapid evolution of the virus and of health recommendations, the study has some conceptual and methodological limitations. Media saturation and collective exhaustion made participation less appealing and influenced the sampling technique that was selected, resulting in a sampling bias caused by a convenience sample. Despite the strategy employed by Léger Marketing Inc., it is difficult to ensure the representativeness of FSMs and English speakers, as well as the potential for statistical generalization of the findings. Furthermore, the survey presents a portrait of FSMs for a given period, rather than according to a specific situation during the pandemic. The time elapsed between the data collection period and the comparative analysis must also be considered a bias for the representativeness of the findings. Despite this, the study met its objective and thus contributed to the active offering of French-language health services.

Impact

This survey provides health professionals with the relevant information they need to tailor their communication with patients who are faced with a vaccination choice. The findings also point to the need for new studies establishing a portrait of FSMs in order to better address their vaccine needs.

Next steps

By filling the knowledge gap regarding vaccination against COVID-19, this data could help improve access to information and, consequently, help adapt the training of health professionals for a therapeutic alliance based on trust.

Conclusion

Although difficult to generalize, this survey did reveal significant differences between FSMs and English speakers in their perceptions of vaccine efficacy, particularly vaccination of children, as well as a polarization of the attitudes/beliefs of FSMs according to certain sociodemographic factors. The findings imply a requirement to better understand the overall needs of FSMs in order to improve access to information and care in French.

Authors’ statement

  • CD — Participation in study design, writing–original draft, data interpretation, writing–revision and editing, final approval
  • JLH — Participation in study design, writing–original draft, data acquisition, data interpretation, writing–revision and editing, final approval
  • JA — Data analysis, writing–revision and editing, final approval
  • MDL — Participation in study design, writing–revision and editing, final approval
  • DH — Participation in study design, writing–revision and editing, final approval
  • SF — Participation in study design, writing–revision and editing, final approval
  • DBL — Participation in study design, final approval
  • SB — Participation in study design, writing–revision and editing, final approval

Competing interests

No conflicts of interest were declared.

Funding

This community survey was funded by the Public Health Agency of Canada.

Acknowledgements

We would like to thank Léger Marketing Inc. for their contribution to the development and distribution of the survey that enabled us to collect the data. We would also like to thank the réseaux de la francophonie that helped distribute the survey.

Supplemental material

These documents can be accessed on the Supplemental material file

Survey, data collection tool

Survey invitation letter and distribution list

References

Footnote 1

Getachew Y, Zephyrin L, Abrams MK, Shah A, Lewis C. M. Doty M. Beyond the Case Count: Wide-Ranging Disparities COVID-19 in U.S. | Commonwealth Fund. Published 2020. [Accessed 2022 Feb 18]. https://www.commonwealthfund.org/publications/2020/sep/beyond-case-count-disparities-covid-19-united-states

Return to footnote 1 referrer

Footnote 2

Cascini F, Pantovic A, Al-Ajlouni Y, Failla G, Ricciardi W. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review. EClinicalMedicine 2021;40:101113. https://doi.org/10.1016/j.eclinm.2021.101113

Return to footnote 2 referrer

Footnote 3

Tang X, Gelband H, Nagelkerke N, Bogoch II, Brown P, Morawski E, Lam T, Jha P; Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators. COVID-19 vaccination intention during early vaccine rollout in Canada: a nationwide online survey. Lancet Reg Health Am 2021;2:100055. https://doi.org/10.1016/j.lana.2021.100055

Return to footnote 3 referrer

Footnote 4

Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother 2013;9(8):1763–73. https://doi.org/10.4161/hv.24657

Return to footnote 4 referrer

Footnote 5

Dubé E, Gagnon D, MacDonald N. Between persuasion and compulsion: the case of COVID-19 vaccination in Canada. Vaccine 2022;40(29):3923–6. https://doi.org/10.1016/j.vaccine.2022.05.053

Return to footnote 5 referrer

Footnote 6

Bouchard L, Desmeules M. [Linguistic minorities in Canada and health]. Healthc Policy 2013;9(Spec Issue):38–47. https://doi.org/10.12927/hcpol.2013.23589

Return to footnote 6 referrer

Footnote 7

Drolet M, Bouchard P, Savard J. Accessibilité et Offre Active: Santé et Services Sociaux En Contexte Linguistique Minoritaire.; 2017. [Accessed 2021 Aug 31]. https://ruor.uottawa.ca/handle/10393/36889

Return to footnote 7 referrer

Footnote 8

Bowen S. The Impact of Language Barriers On Patient Safety and Quality of Care Final Report. Société Santé en français. 2015. https://www.santefrancais.ca/wp-content/uploads/2018/11/SSF-Bowen-S.-Language-Barriers-Study-1.pdf

Return to footnote 8 referrer

Footnote 9

de Moissac D, Bowen S. Impact of language barriers on access to healthcare for official language minority Francophones in Canada. Healthc Manage Forum 2017;30(4):207–12. https://doi.org/10.1177/0840470417706378

Return to footnote 9 referrer

Footnote 10

Health Canada. Social determinants of health and health inequalities. HC; ON: 2020. [Accessed 2022 Feb 18]. https://www.canada.ca/en/public-health/services/health-promotion/population-health/what-determines-health.html

Return to footnote 10 referrer

Footnote 11

Bouchard L. Minorités de Langue Officielle Du Canada: Égales Devant La Santé? Vol 50. PUQ.; 2011.

Return to footnote 11 referrer

Footnote 12

De Moissac D. Accès aux services de santé et d’interprète-accompagnateur : L’expérience des communautés minoritaires à faible densité de francophones au Canada. 2016. [Accessed 2023 Jan 4]. https://savoir-sante.ca/fr/content_page/download/275/446/21?method=view

Return to footnote 12 referrer

Footnote 13

Health Canada. Bowen S. Language Barriers in Access to Health Care. HC; ON: 2001. https://www.canada.ca/en/health-canada/services/health-care-system/reports-publications/health-care-accessibility/language-barriers.html

Return to footnote 13 referrer

Footnote 14

Peters MD. Addressing vaccine hesitancy and resistance for COVID-19 vaccines. Int J Nurs Stud 2022;131:104241. https://doi.org/10.1016/j.ijnurstu.2022.104241

Return to footnote 14 referrer

Footnote 15

Jarrett C, Wilson R, O’Leary M, Eckersberger E, Larson HJ; SAGE Working Group on Vaccine Hesitancy. Strategies for addressing vaccine hesitancy - A systematic review. Vaccine 2015;33(34):4180–90. https://doi.org/10.1016/j.vaccine.2015.04.040

Return to footnote 15 referrer

Footnote 16

Attwell K, Betsch C, Dubé E, Sivelä J, Gagneur A, Suggs LS, Picot V, Thomson A. Increasing vaccine acceptance using evidence-based approaches and policies: insights from research on behavioural and social determinants presented at the 7th Annual Vaccine Acceptance Meeting. Int J Infect Dis 2021;105:188–93. https://doi.org/10.1016/j.ijid.2021.02.007

Return to footnote 16 referrer

Footnote 17

Gualano MR, Olivero E, Voglino G, Corezzi M, Rossello P, Vicentini C, Bert F, Siliquini R. Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review. Hum Vaccin Immunother 2019;15(4):918–31. https://doi.org/10.1080/21645515.2018.1564437

Return to footnote 17 referrer

Footnote 18

Remysen W. Les communautés francophones dans les provinces majoritairement anglophones du Canada : aperçu et enjeux. Trav Linguist. 2019;1(78):15–45. https://doi.org/10.3917/tl.078.0015

Return to footnote 18 referrer

Footnote 19

Health Canada. COVID-19 Vaccination Coverage Survey (CVCS): Cycle 2 full report. HC; ON: 2021. https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/covid-19-vaccination-coverage-survey/full-report-cycle-2.html

Return to footnote 19 referrer

Footnote 20

Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 2004;6(3):e34. https://doi.org/10.2196/jmir.6.3.e34

Return to footnote 20 referrer

Footnote 21

Fullerton MM, Benham J, Graves A, Fazel S, Doucette EJ, Oxoby RJ, Mourali M, Boucher JC, Constantinescu C, Parsons Leigh J, Tang T, Marshall DA, Hu J, Lang R. Challenges and recommendations for COVID-19 public health messaging: a Canada-wide qualitative study using virtual focus groups. BMJ Open 2022;12(4):e054635. https://doi.org/10.1136/bmjopen-2021-054635

Return to footnote 21 referrer

Footnote 22

Colautti L, Cancer A, Magenes S, Antonietti A, Iannello P. Risk-Perception Change Associated with COVID-19 Vaccine’s Side Effects: The Role of Individual Differences. Int J Environ Res Public Health 2022;19(3):1189. https://doi.org/10.3390/ijerph19031189

Return to footnote 22 referrer

Footnote 23

Desson Z, Weller E, McMeekin P, Ammi M. An analysis of the policy responses to the COVID-19 pandemic in France, Belgium, and Canada. Health Policy Technol 2020;9(4):430–46. https://doi.org/10.1016/j.hlpt.2020.09.002

Return to footnote 23 referrer

Footnote 24

Capurro G, Tustin J, Jardine CG, Driedger SM. When good messages go wrong: Perspectives on COVID-19 vaccines and vaccine communication from generally vaccine accepting individuals in Canada. Hum Vaccin Immunother 2022;18(7):2145822. https://doi.org/10.1080/21645515.2022.2145822

Return to footnote 24 referrer

Footnote 25

Tran A, Wallner C, de Wit K, Gérin-Lajoie C, Ritchie K, Mercuri M, Clayton N, Boulos M, Archambault P, Schwartz L, Gray S, Chan TM; Network of Canadian Emergency Researchers. Humans not heroes: canadian emergency physician experiences during the early COVID-19 pandemic. Emerg Med J 2023;40(2):86–91. https://doi.org/10.1136/emermed-2022-212466

Return to footnote 25 referrer

Footnote 26

Falkenbach M, Willison C. Resources or trust: what matters more in the vaccination strategies of high-income liberal democracies? Health Policy Technol 2022;11(2):100618. https://doi.org/10.1016/j.hlpt.2022.100618

Return to footnote 26 referrer

Footnote 27

Drolet M, Dubouloz C, Benoît J. L’accès aux services sociaux et de santé en français et la formation des professionnelles et des professionnels en situation francophone minoritaire canadienne. Reflets Rev d’intervention Soc Communaut. 2014;20(2):10–19. https://doi.org/10.7202/1027584ar

Return to footnote 27 referrer

Footnote 28

Lachance-Grzela M, Charbonneau A, Dubé A, Jbilou J, Richard J. Parents and Caregivers’ Willingness to Vaccinate Their Children Against COVID-19. Can J Behav Sci Epub 2022. https://doi.org/10.1037/cbs0000333

Return to footnote 28 referrer

Footnote 29

Abrams EM, Shaker M, Greenhawt M. La COVID-19 et l’importance d’une communication efficace des risques aux enfants. Paediatr Child Health 2022;27 Suppl 2:S79–81. https://doi.org/10.1093/pch/pxac008

Return to footnote 29 referrer

Footnote 30

Myhre D, Szafran O, Schipper S, Dickinson J, Janke F. Scope of practice of family medicine graduates who completed a rural versus urban program. Rural Remote Health 2018;18(3):4514. https://doi.org/10.22605/RRH4514

Return to footnote 30 referrer

Footnote 31

Malko AV, Huckfeldt V. Physician Shortage in Canada: A Review of Contributing Factors. Glob J Health Sci 2017;9(9). https://doi.org/10.5539/gjhs.v9n9p68

Return to footnote 31 referrer

Page details

Date modified: